OS Therapies to Attend Upcoming Medical, Financial and Industry Conferences
OS Therapies announced its schedule for attending four major medical and financial conferences in late May and June 2026. The company plans to present 2.5-year overall survival data for its lead asset OST-HER2 at ASCO and data at the MIB Agents Factor Osteosarcoma Conference.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.